PIK3C3 and neoplasm: When examining the tumor growth at an early tumor development stage (up to day 19 after tumor implantation (ATI)) through bioluminescence imaging, we found that Vps34-depleted tumors did not show significant difference compared to control tumors (Fig. 7E).